Search Results - "Andreenko, E. Yu"

Clinical and Anamnestic Characteristics, Cardiovascular Pharmacotherapy and Long-term Outcomes in Multimorbid Patients after COVID-19 by Smirnov, A. A., Loukianov, M. M., Martsevich, S. Yu, Pulin, A. A., Kutishenko, N. P., Andreenko, E. Yu, Voronina, V. P., Dindikova, V. A., Dmitrieva, N. A., Kudryavtseva, M. M., Lerman, O. V., Makoveeva, A. N., Okshina, E. Yu, Maltseva, A. A., Belova, E. N., Klyashtorniy, V. G., Kudryashov, E. V., Karpov, O. E., Drapkina, O. M.

“…Aim. To study the clinical and anamnestic characteristics, pharmacotherapy of cardiovascular diseases (CVD) and long-term outcomes in post-COVID-19 patients…”
Get full text

"They are closely interconnected, complement each other and pass into each other, there are no clear boundaries between them". Case report by Rogozhkina, E. A., Ershova, A. I., Andreenko, E. Yu, Beregovskaya, S. A.

“…Hereditary angioedema is a rare (1:50,000) hereditary chronic disease from the group of primary immunodeficiencies, which manifests in the form of recurrent…”
Get full text

Outpatient-Polyclinic Register of the Multidisciplinary Medical Center (TERRA): general characteristics and first results by Lukyanov, M. M., Andreenko, E. Yu, Smirnov, A. A., Kudryavtseva, M. M., Kuzina, N. N., Klyashtorny, V. G., Shepel, R. N., Ryzhakova, L. N., Drapkina, O. M.

“…Aim. To describe the experience of creating the Outpatient-Polyclinic Register of the Multi-specialty Medical Center (TERRA) and the first results of the…”
Get full text

Two-year outcomes in patients after hospitalization for COVID-19: data from the TARGET-VIP registry by Lukyanov, M. M., Andreenko, E. Yu, Martsevich, S. Yu, Kutishenko, N. P., Voronina, V. P., Dindikova, V. A., Dmitrieva, N. A., Kudryavtseva, M. M., Lerman, O. V., Makoveeva, A. N., Okshina, E. Yu, Pulin, A. A., Smirnov, А. А., Klyashtorny, V. G., Karpov, O. E., Drapkina, O. M.

“…Aim . To evaluate 24-month outcomes after hospital treatment of patients with coronavirus disease 2019 (COVID-19) in a prospective registry. Material and…”
Get full text

Outpatient register of patients who have suffered a myocardial infarction (REGATA): prospective follow-up data and outcomes by Pereverzeva, K G, Lukyanov, M M, Andreenko, E Yu, Klyashtorny, V G, Pravkina, E A, Drapkina, O M, Yakushin, S S

“…Aim      To determine the factors that influence the long-term prognosis in patients after myocardial infarction (MI) as a part of the prospective REGistry of…”
Get more information

Detection rate and characteristics of heart failure, depending on the diagnostic criteria in COVID-19 survivors one year after hospitalization by Mareev, Yu. V., Lukyanov, M. M., Martsevich, S. Yu, Pulin, A. A., Kutishenko, N. P., Andreenko, E. Yu, Voronina, V. P., Dindikova, V. A., Dmitrieva, N. A., Makoveeva, A. N., Lerman, O. V., Okshina, E. Yu, Smirnov, A. A., Kudryavtseva, M. M., Belova, E. N., Klyashtorny, V. G., Kudryashov, E. V., Karpov, O. E., Drapkina, O. M.

“…Aim. To estimate the detection rate of heart failure (HF), using various diagnosis criteria, among patients aftr 12 months after hospital treatment for…”
Get full text

Medical treatment of patients with cardiovascular diseases during the first year after hospitalization for COVID-19 by Kutishenko, N. P., Lukyanov, M. M., Martsevich, S. Yu, Pulin, A. A., Andreenko, E. Yu, Voronina, V. P., Dindikova, V. A., Dmitrieva, N. A., Kudryavtseva, M. M., Lerman, O. V., Makoveeva, A. N., Okshina, E. Yu, Smirnov, А. А., Belova, E. N., Klyashtorny, V. G., Kudryashov, E. V., Karpov, O. E., Drapkina, O. M.

“…Aim. To evaluate the medical treatment of patients with cardiovascular disease (CVD) during the first year of follow-up after hospitalization for coronavirus…”
Get full text

Long-term outcomes in patients after COVID-19: data from the TARGET-VIP registry by Lukyanov, M. M., Kutishenko, N. P., Martsevich, S. Yu, Pulin, A. A., Andreenko, E. Yu, Voronina, V. P., Dindikova, V. A., Dmitrieva, N. A., Lerman, O. V., Makoveeva, A. N., Okshina, E. Yu, Sgibneva, A. S., Smirnov, A. A., Belova, E. N., Klyashtorny, V. G., Kudryashov, E. V., Karpov, O. E., Drapkina, O. M.

“…Aim . To assess long-term outcomes within 12 months after hospital treatment of patients with coronavirus disease 2019 (COVID-19) as part of a prospective…”
Get full text

Prehospital Period in Patients with COVID-19: Cardiovascular Comorbidity and Pharmacotherapy During the First Epidemic Wave (Hospital Registry Data) by Martsevich, S. Yu, Lukyanov, M. M., Pulin, M. M., Kutishenko, N. P., Andreenko, E. Yu, Voronina, V. P., Dindikova, V. A., Dmitrieva, N. A., Zagrebelnyy, A. V., Lerman, O. V., Makoveeva, A. N., Okshina, E. Yu, Smirnov, A. A., Kudryashov, E. V., Budaeva, I. V., Nikoshnova, E. S., Karpov, O. E., Drapkina, O. M.

“…Aim . Based on the data from the register of patients with COVID-19 and community-acquired pneumonia (CAP), analyze the duration of the prehospital period,…”
Get full text

Dynamics of age characteristics and prevalence of concomitant cardiovascular and non-sardiovascular diseases in patients hospitalized with COVID-19 during epidemic wave: data from TARGET-VIP registry by Lukyanov, M. M., Martsevich, S. Yu, Pulin, A. A., Kutishenko, N. P., Andreenko, E. Yu, Voronina, V. P., Dindikova, V. A., Dmitrieva, N. A., Zagrebelny, A. V., Makoveeva, A. N., Lerman, O. V., Okshina, E. Yu, Sgibneva, А. S., Smirnov, A. A., Belova, E. N., Klyashtorny, V. G., Kudryashov, E. V., Karpov, O. E., Drapkina, O. M.

“…Aim. According to hospital-based registry, to evaluate the age characteristics and prevalence of concomitant cardiovascular and non-сardiovascular diseases in…”
Get full text

Early cardiovascular multimorbidity in out- and in-patient care: age characteristics and medication therapy (data from the REKVAZA and REKVAZA-CLINIC registries) by Andreenko, E. Yu, Lukyanov, M. M., Yakushin, S. S., Makoveeva, A. N., Vorobiev, A. N., Pereverzeva, K. G., Kudryashov, E. V., Klyashtorny, V. G., Dindikova, V. A., Smirnov, A. A., Boytsov, S. A., Drapkina, O. M.

“…Aim. To assess the age and sex characteristics, comorbidities and medication therapy in patients with early cardiovascular multimorbidity in out- and…”
Get full text

Young ambulatory patients with cardiovascular diseases: age and gender characteristics, comorbidity, medication and outcomes (according to RECVASA register) by Andreenko, E. Yu, Lukyanov, M. M., Yakushin, S. S., Vorobyev, A. N., Kudryashov, E. V., Yavelov, I. S., Klyashtorny, V. G., Pereverzeva, K. G., Boytsov, S. A., Drapkina, O. M.

“…Aim. To assess age and gender characteristics and determine comorbidity, medication, and outcomes in young ambulatory patients with cardiovascular diseases…”
Get full text

Patients with Atrial Fibrillation in Clinical Practice: Comorbidity, Drug Treatment and Outcomes (Data from RECVASA Registries) by Loukianov, M. M., Andreenko, E. Yu, Martsevich, S. Yu, Yakushin, S. S., Vorobyev, A. N., Pereverzeva, K. G., Zagrebelnyy, A. V., Okshina, E. Yu, Yakusevich, V. V., Yakusevich, V. Vl, Pozdnyakova, E. M., Gomova, T. A., Fedotova, E. E., Valiakhmetov, M. N., Mikhin, V. P., Maslennikova, Yu. V., Klyashtorny, V. G., Kudryashov, E. V., Tatsii, Ju. E., Boytsov, S. A., Drapkina, O. M.

“…Aim . To study comorbidity, drug therapy and outcomes in patients with atrial fibrillation (AF) included in the outpatient and hospital RECVASA registries…”
Get full text

Patients with a Combination of Atrial Fibrillation and Chronic Heart Failure in Clinical Practice: Comorbidities, Drug Treatment and Outcomes by Loukianov, M. M., Martsevich, S. Yu, Mareev, Yu. V., Yakushin, S. S., Andreenko, E. Yu, Vorobiev, A. N., Pereverzeva, K. G., Zagrebelny, A. V., Okshina, E. Yu, Yakusevich, V. V., Yakusevich, Vl. Vl, Pozdnyakova, E. M., Gomova, T. A., Fedotova, E. E., Valiakhmetov, M. N., Mikhin, V. P., Maslennikova, Yu. V., Belova, E. N., Klyashtorny, V. G., Kudryashov, E. V., Makoveeva, A. N., Tatsiy, Yu. E., Boytsov, S. A., Drapkina, O. M.

“…Aim . To assess in clinical practice the structure of multimorbidity, cardiovascular pharmacotherapy and outcomes in patients with a combination of atrial…”
Get full text

PATIENTS WITH COMBINATION OF CHRONIC HEART FAILURE, HYPERTENSION AND HISTORY OF MYOCARDIAL INFARCTION: CLINICAL AND ANAMNESTIC CHARACTERISTICS, ADMINISTRATION OF ACE INHIBITORS, ANGIOTENSIN RECEPTOR BLOCKERS, -BLOCKERS AND ADHERENCE TO THE DRUG THERAPY (DATA OF OUTPATIENT REGISTRY RECVASA) by Loukianov, M. M., Kozminsky, A. N., Martsevich, S. Yu, Yakushin, S. S., Vorobyev, A. N., Zagrebelnyy, A. V., Myasnikov, R. P., Pereverzeva, K. G., Pravkina, E. A., Andreenko, E. Yu, Belova, E. N., Deev, A. D., Klyashtorny, V. G., Kudryashov, E. V., Boytsov, S. A.

“…Aim. To assess the clinical and anamnestic characteristics, the prescription rate of angiotensin converting enzyme inhibitors (ACEI)/angiotensin receptor…”
Get full text

THE OUTPATIENT BASED REGISTRY RECVASA: PROSPECTIVE FOLLOW-UP DATA, RISK EVLUATION AND OUTCOMES IN CARDIOVASCULAR PATIENTS by Boytsov, S. A., Lukyanov, М. М., Yakushin, S. S., Martsevich, S. Yu, Vorobyev, A. N., Zagrebelny, A. V., Pereverzeva, K. G., Pravkina, Е. А., Deev, A. D., Andreenko, E. Yu, Ershova, A. I., Meshkov, A. N., Myasnikov, R. P., Serdyuk, S. S., Kharlap, M. S., Bazaeva, E. V., Kozminsky, A. N., Moseychuk, K. A., Klyashtorny, V. G., Kudryashov, E. V.

“…Aim. To evaluate, under the frame of prospective registry, the 12-month outcomes and risks in patients with arterial hypertension (AH), ischemic heart disease…”
Get full text

THE SPECIFICS OF NONCOMPACTED CARDIOMYOPATHY MANIFESTATION by Myasnikov, R. P., Blagova, O. V., Kulikova, O. V., Mershina, E. A., Kharlap, M. S., Andreenko, E. Yu, Koretsky, S. N., Serdyuk, S. E., Bazaeva, E. V., Virabova, I. A., Beregovskaya, S. A., Sinitsyn, V. E., Boytsov, S. A.

“…Noncompacted myocardium of the left ventricle (NMLV), or noncompacted cardiomyopathy, according to the World Health Organization classification is a…”
Get full text

OUTPATIENT REGISTER OF CARDIOVASCULAR DISEASES IN THE RYAZAN REGION (RECVASA): PRINCIPAL TASKS, EXPERIENCE OF DEVELOPMENT AND FIRST RESULTS by Boytsov, S. A., Yakushin, S. S., Martsevich, S. Yu, Lukyanov, M. M., Nikulina, N. N., Zagrebelny, A. V., Vorobyov, A. N., Pereverseva, K. G., Pravkina, E. A., Deev, A. D., Andreenko, E. Yu, Ershova, A. I., Meshkov, A. N., Myasnikov, R. P., Serdyuk, S. E., Kharlap, М. S.

“…Aim. To estimate risk factors and comorbidity structure, cardiovascular diseases outcomes, evaluate their diagnostics and treatment quality in real outpatient…”
Get full text

CARDIOVASCULAR DISEASES REGISTRY (RECVAZA): DIAGNOSTICS, CONCOMITANT CARDIOVASCULAR PATHOLOGY, COMORBIDITIES AND TREATMENT IN THE REAL OUTPATIENT-POLYCLINIC PRACTICE by Boytsov, S. A., Luk’yanov, M. M., Yakushin, S. S., Martsevich, S. Yu, Vorobyov, A. N., Zagrebelny, A. V., Pereverzeva, K. G., Pravkina, E. A., Deev, A. D., Andreenko, E. Yu, Ershova, A. I., Meshkov, A. N., Myasnikov, R. P., Serdyuk, S. S., Kharlap, M. S., Bazaeva, E. V., Kozminsky, A. N., Moseychuk, K. A., Kudryashov, E. N.

“…Aim. To study the structure of concomitant cardiovascular and comobid pathology, risk factors in patients with arterial hypertension (AH), coronary heart…”
Get full text

Endothelial NO synthase and connexin 37 gene polymorphisms as a risk factor for myocardial infarction in subjects without a history of coronary artery disease by Balatskiĭ, A V, Andreenko, E Yu, Samokhodskaya, L M, Boĭtsov, S A, Tkachuk, V A

“…To define a role of connexin37 (Cx37) C1019T and endothelial nitric oxide synthase (eNOS) G894T polymorphisms in the development of myocardial infarction (MI)…”
Get full text